Medable Secures $304M in Series D Funding

Clinical research company Medable has secured $304 million in Series D funding, marking its fourth round since 2020, giving the firm a valuation of just over $2 billion. Dr. Michelle Longmire, CEO and Co-founder, Medable joined Cheddar's Opening Bell to discuss the future of the company.
More Videos
CES 2025: Top Tech to Watch
Jason Hiner, Editor in Chief of ZDNET, breaks down the best tech that came out of CES 2025, including Nvidia's Cosmos, New TV Tech, Roborok Saros Z70 and more.
Load More